Crossmark

The utility of arterial spin labeling imaging for predicting prognosis after a recurrence of high-grade glioma in patients under bevacizumab treatment

Crossref DOI link: https://doi.org/10.1007/s11060-023-04550-w

Published Online: 2024-01-02

Published Print: 2024-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kambe, Atsushi http://orcid.org/0000-0002-7173-5915
Kitao, Shinichiro

Ochiai, Ryoya

Hosoya, Tomohiro

Fujii, Shinya

Kurosaki, Masamichi
Funding

Funding for this research was provided by:

Japan Society for the Promotion of Science (JP20K08135, JP20K08135, JP20K08135, JP20K08135)
License Information

Text and Data Mining valid from 2024-01-01

Version of Record valid from 2024-01-01
More Information

Article History

Received: 26 November 2023

Accepted: 20 December 2023

First Online: 2 January 2024

Declarations

:

: This retrospective study was approved by our Institutional Review Board, and the requirement for informed consent was waived because of the retrospective nature of this study (approval no. 23A018).

: The authors have no relevant financial or non-financial interests to disclose.

Document is current

Any future updates will be listed below